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Abstract

Significance: Proton-electron double-resonance imaging (PEDRI) employs electron paramagnetic resonance irradiation with low-field magnetic resonance imaging so that the electron spin polarization is transferred to nearby
protons, resulting in higher signals. PEDRI provides information about free radical distribution and, indirectly,
about the local microenvironment such as partial pressure of oxygen (pO2), tissue permeability, redox status, and
acid-base balance.
Recent Advances: Local acid-base balance can be imaged by exploiting the different resonance frequency of
radical probes between R and RH+ forms. Redox status can also be imaged by using the loss of radical-related
signal after reduction. These methods require optimized radical probes and pulse sequences.
Critical Issues: High-power radio frequency irradiation is needed for optimum signal enhancement, which may
be harmful to living tissue by unwanted heat deposition. Free radical probes differ depending on the purpose of
PEDRI. Some probes are less effective for enhancing signal than others, which can reduce image quality. It is so
far not possible to image endogenous radicals by PEDRI because low concentrations and broad line widths of
the radicals lead to negligible signal enhancement.
Future Directions: PEDRI has similarities with electron paramagnetic resonance imaging (EPRI) because both
techniques observe the EPR signal, directly in the case of EPRI and indirectly with PEDRI. PEDRI provides
information that is vital to research on homeostasis, development of diseases, or treatment responses in vivo. It
is expected that the development of new EPR techniques will give insights into novel PEDRI applications and
vice versa. Antioxid. Redox Signal. 28, 1345–1364.
Keywords: Overhauser MRI, OMRI, PEDRI, free radical, imaging
Introduction:

P

roton-electron double-resonance imaging (PEDRI), also known as Overhauser-enhanced magnetic
resonance imaging (OMRI), is an imaging modality with
similarities to MRI as well as to Electron Paramagnetic Resonance Imaging (EPRI). It is usually carried out at extremely
low magnetic fields of 10–40 mT corresponding to proton
Larmor frequencies of 0.5–2 MHz and electron Larmor frequencies of 300–1200 MHz. At such low magnetic fields, the
polarization of the 1H spin states is small, making it difficult to
generate MR images with a useful signal-to-noise ratio (SNR).

However, in the presence of paramagnetic species with narrow
electron paramagnetic resonances (EPRs), application of
electromagnetic radiation at the resonance frequency of the
electron spins (typically at radio frequency) significantly enhances the nuclear polarization to a theoretical maximum of
330-fold (half of ce/cp = 659), where ce and cp are, respectively,
the electron and proton gyromagnetic ratios. Under these circumstances, due to dipolar coupling between the unpaired
electrons and the solute (water) protons in the system, polarization is transferred to nearby protons, creating much larger
population differences between the nuclear spin states, in turn
leading to a large increase in signal intensity (48, 49, 79, 114).
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This method is known as the Overhauser effect, or sometimes
as liquid-state Dynamic Nuclear Polarization (DNP). The
saturation of electrons is carried out for a duration in the order
of the proton spin lattice relaxation time, after which the ç
detection and spatial encoding follow immediately, resulting
in a significant enhancement of the proton signals. Images
with useful SNR can be acquired in such a manner even at
such low magnetic fields. Further, PEDRI is effectively an
indirect form of EPRI in the sense that the enhancement of
proton signals is proportional to the concentration of the
paramagnetic system and the degree of saturation of the EPR
system. In a PEDRI image, regions of the sample containing
free radicals ‘‘light up’’ due to the Overhauser-enhanced
proton nuclear magnetic resonance (NMR) signal, revealing
the location of the free radical. This review covers the topic of
PEDRI from the historical background to various preclinical
applications of the technique, including partial pressure of
oxygen (pO2) mapping, permeability mapping, redox mapping, and pH mapping.
Historical Background

DNP of nuclear spin states was predicted by Albert
Overhauser in 1953 (100), a technique that became known as
the Overhauser effect. In the theory, saturating the electron
spin resonance of a paramagnetic species will significantly
enhance the polarization of surrounding nuclear spins. This
prediction was confirmed by Carver and Slichter in 1956 who
had been researching the electron spin resonance of lithium
(20). In the process of experimental verification of the
Overhauser effect, they concluded that the effect could be
observed in any system in which the nuclear relaxation was
dominated by a coupling to electrons in which the nuclear
spin flip requires a simultaneous electron flip. To further
verify these conclusions, they successfully performed experiments on systems of 7Li, 23Na, and even 1H (20). The
Nuclear Overhauser Effect (NOE) is an extension of the
Overhauser effect explained with experimental observation
by Kaiser in 1962, demonstrating polarization transfer from
one population of nuclear spins to another via cross relaxation
(65). The NOE is utilized in the field of NMR spectroscopy,
including its use to determine the three-dimensional structure
of complex molecules. Here, we focus on the Overhauser effect where electron spin polarization is transferred to 1H polarization with subsequent MRI to reveal the localized
concentration of free radicals.
The ability to image the distribution of paramagnetic solutions in vivo has many potential uses in biology and medicine.
EPRI, which uses methods analogous to those employed in
NMR imaging, has been developed with considerable effort (8,
9, 31, 38, 85). However, EPR was typically restricted to small
samples (*50 mm) because of the relatively large line widths
(*MHz) and the strong gradients necessary to achieve useful spatial resolution. Endogenous free radicals are present
in small quantities and are often short-lived with a very low
steady-state concentration. Therefore, it is necessary to introduce free radicals as ‘‘probes’’ into the living system that should
be biocompatible, stable during the measurement, and nontoxic.
Oxygen concentration in tissues can be deduced via its linebroadening effect on the EPR spectrum of injected free radical.
To image paramagnetic species such as injected free radicals in larger-sized biological systems and animals, Lurie
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et al. developed in 1988 an imaging technique that combines
proton NMR imaging with the Overhauser effect, called
PEDRI, which is also known as OMRI (79). The main difference between PEDRI and EPRI is that the enhanced proton
signal is observed in PEDRI, whereas the electron signal
from the free radical probe is observed directly in EPRI.
Unlike EPRI, large sample sizes with higher resolution can be
achieved in PEDRI because proton resonances are detected
after enhancement by the Overhauser effect. The terms
PEDRI and OMRI represent one and the same technique;
throughout this article, we will use PEDRI.
Under appropriate conditions, EPR irradiation causes a
transfer of polarization from the unpaired electrons to the
proton nuclei of tissue water, increasing the intensity of the
1
H NMR signal. The enhancement of the NMR signal can be
described by the enhancement factor, E, given by:
E ¼ AZ =A0

[1]

where AZ and A0 are the NMR signals with and without
EPR irradiation, respectively. The enhancement can be described by the following relationship:
E ¼ 1  qf ðs=nÞ(ce=cp)

[2]

where q is the coupling factor (-1 £ q £ 1/2, with q = 1/2
for dipole–dipole interactions), f is the leakage factor (0 £
f £ 1), s is the saturation factor (0 £ s £ 1), n is the number of
hyperfine lines in the EPR spectrum (n = 3 for a typical
nitroxide-free radical), and ce and cp are the electron and
nuclear gyromagnetic ratios (for experiments involving
protons, the ratio [ce/cp & 659]). Equation [2] assumes that
only one EPR resonance is irradiated at a time (81).
Figure 1 shows the capability of PEDRI to provide 1H
images at low magnetic fields and to assess the influence of

FIG. 1. PEDRI magnitude image of two phantom tubes
containing air-equilibrated (left) and nitrogen-equilibrated
(right) 2.5 mM TEMPOL solution dissolved in water (79).
Due to different oxygen concentration, the magnitude of
enhancement is higher in the right phantom tube. Calculated enhancement factors were -6.9 (left) and -9.8 (right).
Reprinted by permission from Lurie et al. (79). PEDRI,
proton-electron double-resonance imaging; TEMPOL, 4Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl.
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dissolved oxygen on the enhancement (79). Two identical
phantom tubes were filled with 2.5 mM 4-hydroxy-2,2,6,6tetramethylpiperidine-1-oxyl (TEMPOL) solution dissolved
in water, one of which had been equilibrated with nitrogen by
bubbling the gas through the phantom and the other with air.
The nitrogen-equilibrated phantom exhibited a 40% greater
enhancement than the air-equilibrated one with calculated
enhancement factors of -6.9 (left) and -9.8 (right). This effect occurs because EPR resonances of spin labels are differentially broadened in the presence of dissolved oxygen
(13, 46, 100, 117). A broad EPR line is more difficult to
saturate; thus, the observed enhancement factor for a given
magnetic field strength is reduced. PEDRI images have been
obtained with TEMPOL concentrations as low as 0.3 mM,
which is, nevertheless, more than three orders of magnitude
higher than the concentration of intrinsic radicals (84).
Field Cycling

To make PEDRI applicable for in vivo experiments by
avoiding excessive sample heating due to high power of EPR
irradiation, field cycling (FC) was introduced in the pulse
sequence of image acquisition, which greatly reduces the
applied field strength during EPR irradiation (82). In FCPEDRI, the magnetic field applied to the sample is changed
throughout the experiment. Figure 2 shows the pulse sequence of FC-PEDRI. The EPR irradiation is applied at low
magnetic field strength (at a correspondingly low frequency),
during which the Overhauser polarization transfer alters the
proton magnetization (Evolution Period). The magnetic field
is then increased rapidly for the detection period, during
which the NMR detection pulse(s) and magnetic field gradients are applied (Detection Period). Applying the EPR irradiation at a low field decreases the EPR frequency and the
nonresonant power deposition (which varies approximately
as the square of the frequency), allowing larger samples to
be used. The optimum EPR frequency as well as evolution
field depends on the EPR linewidth of the free radical and
on the size of the sample. It has previously been shown that
with nitroxide-free radicals and large samples, the optimum
frequency is between 30 and 60 MHz, corresponding to an

FIG. 2. FC-PEDRI pulse sequence,
showing magnetic field, field gradient, and
waveforms. Reprinted with permission
from IOP Publishing from Lurie et al. (81).
ª Institute of Physics and Engineering in
Medicine. All rights reserved. FC, field cycling.
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Evolution (EPR) field of *3 mT (78). Detecting the NMR
signals at a high field is necessary to increase the SNR of the
experiment.
Figure 3 shows FC-PEDRI images of a resolution phantom
(B–D); a field-cycled non-PEDRI image (A) is also shown for
comparison (82). The center of the phantom consisted of five
tubes of internal diameters 15, 9, 5, 4, and 3 mm filled with
2 mM TEMPOL solution. These were enclosed in a cylindrical container of diameter 4 cm that was filled with water
doped with copper sulfate to give the same T1 as that of the
free radical solution (650 ms at 2.5 MHz). Fourteen sample
tubes with internal diameters of 8 mm were attached around
the outside of the cylinder, with alternate tubes being filled
with 2 mM TEMPOL solution or copper sulfate-doped water.
The overall diameter of the phantom was 6 cm, about the size
of a small rat. The three FC-PEDRI images were obtained by
using EPR irradiation time (TEPR) values of 750, 1000, and
1500 ms with a repetition time of 2000 ms, and the average
observed enhancement factors were -4.0, -5.3, and -7.1,
respectively. The instantaneous power level in the EPR irradiation was approximately 7 W/kg, whereas the average
applied power ranged from 2.7 to 5.3 W/kg depending on the
pulse sequence timing. In FC-PEDRI, the enhanced versus
unenhanced image intensity ratio depends not only on the
power of the EPR irradiation but also on the relative timing of
the polarization and evolution intervals, and the values of B0P
and B0D. At the beginning of the evolution period, the size of
the magnetization depends on the length of the polarization
period compared with the sample’s T1 at B0P. During the
evolution period, the magnetization decays at a rate determined by the sample’s T1 at B0E. Meanwhile, the magnetization in regions of the sample containing free radical
increases at a rate depending on T1 toward an equilibrium
value that depends on the EPR irradiation power. The results
from FC-PEDRI show that free radicals can be imaged with
greater resolution than with EPR, which typically relies on
projection reconstruction.
In vivo experiments using FC-PEDRI have been reported.
Figure 4 shows images from an in vivo experiment using the
nitroxide radical proxyl carboxylic acid (PCA) in the rabbit
(81). An anesthetized rabbit was placed supine with the
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FIG. 3. Images of phantom containing 2 mM TEMPOL
solution and copper sulfate-doped water. Images are
64 · 64 sections of original 128 · 128 images, which had
15 cm field of view, 15 mm slice thickness. All images are
field-cycled, with B0P = B0D = 0.01 T, B0E = 0.005 1 T,
saturation-recovery NMR sequence with TR = 2000 ms, four
averages. Image (A) has TEPR = 1000 ms, no EPR irradiation.
Images (B–D) have EPR irradiation at 160 MHz, power 1 W.
Image (B) has TEPR = 750 ms; observed enhancement factor
E = -4.0. Image (C) has TEPR = 1000 ms; E = -5.3. Image (D)
has TEPR = 1500 ms; E = -7. I. Reprinted with permission from
Lurie et al. (82). TEPR, EPR irradiation time. NMR, nuclear
magnetic resonance; EPR, electron paramagnetic resonance.
kidneys placed centrally, and an FC-PEDRI image was collected. The free radical probe was then administered, and a
series of FC-PEDRI images was obtained at approximately
6 min intervals. Images were obtained by using both 64 · 64
and 128 · 128 matrices. In both cases, the image parameters
were: field of view 15 cm, slice thickness 3 cm, TR = 1000 ms,
TEPR = 300 ms, T ramp = 40 ms, T stab = 10 ms, EPR frequency
51.0 MHz, and B0E = 3.05 mT. The forward power to the
birdcage resonator was approximately 300 W, and the power
absorbed in the animal can be estimated as 130 W by using
the loaded and unloaded Q factors (measured to be 193 and
346, respectively). Considering the duty cycle of the EPR
irradiation (300 ms in 2000 ms, or 15%), the average specific
absorption rate (SAR) in the 2.2 kg animal is 9 Wkg-1.
Considering the delays between consecutive image collections, the overall SAR was only 3 W kg-1. Although this
is still higher than desirable, the experiment successfully
demonstrated that FC-PEDRI of a moderately large animal
was possible without overheating the animal due to nonresonant absorption of the EPR irradiation. Figure 4 shows
‘‘without EPR,’’ ‘‘with EPR,’’ and ‘‘difference’’ transaxial
images through the animal’s abdomen obtained 2 min after
injection of the nitroxide-free radical. As reported in the rat
(111), PCA is cleared through the rabbit’s kidneys, and this
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FIG. 4. Trans-axial images through abdomen of anesthetized rabbit after injection of PCA nitroxide-free
radical. (A) ‘‘without EPR’’ image, (B) ‘‘with EPR’’ image,
(C) ‘‘difference’’ image. The difference image shows the
animal’s kidneys and major blood vessels. The high-intensity
region above the animal is a reference vial containing 1 mM
PCA solution. Vials containing CuSO4 solution are seen below the animal in (A, B); these are used to aid positioning.
Reprinted with permission of IOP Publishing from Lurie et al.
(81). ª Institute of Physics and Engineering in Medicine. All
rights reserved. PCA, proxyl carboxylic acid.
can be seen clearly in the difference image, together with
major blood vessels. The SNR in the difference image was
measured to be 14 – 1.5 (81).
Optimization of Probes for PEDRI

The feasibility of in vivo application of PEDRI had been
intensively researched by several groups in the literature in
the 1990s. However, nitroxides used as contrast media in the
studies until the late 1990s were not optimized enough to
produce morphological images at *10 mT (3, 47, 79, 82).
The nitrogen nucleus has a spin 1 and splits the single transition into three transitions. So, when one transition is irradiated, only 1/3 of the possible enhancement is available and
high power is needed to saturate it due to the short relaxation
time. Both these factors result in restricted enhancement and,
consequently, a low SNR in the resulting images. In addition,
the short pharmacological half-lives of these species further
limited their use for PEDRI research. To improve the SNR of
in vivo PEDRI, triarylmethyl or trityl radicals (TAM), paramagnetic substances with single narrow lines and a long relaxation time were synthesized as probes (4, 17, 44, 105, 131,
134). Figure 5A shows the chemical structural formula of
TAM, and Figure 5B illustrates the case of F when it is Ox63.
The narrow line without splitting was realized by designing
the location of unpaired electron more than five bonds away
from magnetic nuclei. The carboxyl group in F makes TAM

PROTON-ELECTRON DOUBLE-RESONANCE IMAGING
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FIG. 5. (A, B) Chemical structure of TAM. Reprinted
with permission from Krishna et al. (75). TAM, trityl radical.
highly soluble. TAM distributes in extracellular space due to
its negative charge. TAM also has other characteristics that
are needed for EPR probe (stability, low toxicity, long in vivo
half-lives, and pO2-dependent EPR line widths).
By combining these probes with improved imaging hardware and pulse sequences, significant improvements in the
quality of morphological images in rats were reported in 1998
(44). That study also showed that TAM behaved pharmacokinetically as an extravascular, extracellular MR contrast
medium, which indicated that it remains mainly within the
vascular bed during the first few re-circulations in the body.
In vivo images from another study are illustrated in Figure 6,
which shows the difference between unenhanced MRI and
PEDRI by using TAM in a mouse at 20 mT. The PEDRI
image displays significantly higher SNR, though both images
were taken in comparable times. The imaging parameters are
listed in the figure caption (83).
Figure 7 also shows a set of coronal FC-PEDRI images
(EPR-on, EPR-off and difference, Fig. 7A–C respectively) of
a 172 g rat, 51 min after injection of a dose of TAM; imaging
parameters are listed in the figure caption (80). These images
illustrate the advantage of using a relatively high-detection
magnetic field (0.45 T) to boost the overall SNR, with an
attendant increase in sensitivity and image quality. A slice
thickness of 30 mm was used to visualize the injected free
radicals independent of its anterior–posterior position within
the animal. In the difference image, the animal’s kidneys and
bladder can clearly be seen. The ureters are also clearly
visible, even though they represent only a small fraction of
the volume of a voxel (the voxel dimensions are 30/0.8/
0.8 mm). It is also noteworthy that by using TAM the imaging
of renal excretion has improved substantially from Figure 4
using PCA.
pO2 Mapping with PEDRI

Oxygen supply and diffusion into tissues is necessary for
cellular function (19). The oxygen pO2, which is a key
measure of the physiological state of an organ, results from
the balance between oxygen delivery and its consumption.
Oxygen transported by red blood cells is delivered dependent
on the metabolic requirements and functional status of each
organ. Tissue oxygenation is severely disturbed during
pathological conditions such as cancer, diabetes, coronary
heart disease, stroke, etc., which are associated with a decrease in pO2 (19). Several different techniques have been
developed to quantify the concentration of oxygen. Invasive
methods involve oxygen sensitive electrodes such as the

FIG. 6. PEDRI (a) and MRI (b) images of an aesthetized mouse. (a) Projective coronal gradient-echo PEDRI
image of an anesthetized 30-g mouse 3 min after administration of i.v. dose of 0.66 mmol/kg TAM. Image shows an
enhancement of -5 in the kidneys and major blood vessels.
Image parameters: matrix size 128 · 128; FOV 8 · 8 cm; TR
1200 ms; TE 12 ms; EPR irradiation time 400 ms; NEX 1;
EPR irradiation at 564 MHz. The applied EPR irradiation
power at the resonator was 3 W with 26% absorbed by the
30-gm mouse, resulting in an SAR of 7.4 W/kg during the 2min 40-s acquisition time. (b) Image of the same animal
without EPR irradiation (other parameters are identical).
Reprinted with permission from Lurie et al. (83).
Clark electrode (51, 54) or the Eppendorf electrode (127,
130). As noninvasive methods, the blood oxygenation leveldependent MRI techniques (16, 96, 99) where a T2*-sensitive
gradient echo pulse sequence is used to visualize the ratio
between oxy/deoxy-hemoglobin and nonhydrogen nuclei
such as 17O (89, 97, 136) or 19F MR images (88, 101, 107)
where the oxygen concentration is reflected in the signal intensity of the image are available.
The electron spin relaxation times are mainly determined
by self-broadening and oxygen-induced relaxation (1, 35, 39,
40, 67, 118, 120, 137). In PEDRI, the presence of O2 shortens
the relaxation times and, consequently, results in the decreased
transfer of polarization to nuclear spins during the EPR irradiation. Variations in the concentration of the unpaired electron substance can also influence the electron spin relaxation
times in the same way. Hence, the signal intensity of PEDRI
can be calculated by using both oxygen concentration and
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FIG. 7. Images of 172-g anesthetized rat, 51 min after injection of 0.58 mmol/kg iv dose of TAM. (A) Image acquired
with EPR irradiation; (B) image acquired without EPR irradiation; (C) difference image; labels: RK—right kidney, LK—
left kidney, B—bladder. Acquisition parameters: 128 · 128 matrix; field of view, 100 · 100 mm; slice thickness, 30 mm;
NEX 1; TR, 1050 ms; TEPR, 400 ms; B0E, 3.30 mT; EPR irradiation, 93.1 MHz, 15 W applied power. Reprinted with permission
from Lurie et al. (80).
concentration of radical probe on the relaxation rates. Thus,
in vivo oximetry is one of the most straightforward and useful
applications of PEDRI (4, 32, 75, 79, 92). EPR methods (both
spectroscopic and imaging) are also employed to obtain oxygen information. In EPRI, the spatial as well as the spectral
information of the exogenously administered spin probes is
obtained. Therefore, EPRI present the in vivo visualization of
the spin probes but without complementary anatomical information. In contrast, MRI is a well-established modality that
gives superior anatomical information. PEDRI uses the
Overhauser effect, thereby indirectly detecting the EPR signal.
After the EPR irradiation, using standard MR-imaging techniques, distribution of the probe and the oxygen concentration
near the probe is visualized in PEDRI (4, 45, 117, 128). In vivo
applications of PEDRI oximetry have been demonstrated, for
example by Golman et al. (45).
In the oncology field, approximately one-third of human
tumors evaluated for oxygen status have shown significant
oxygen deficiency. Oxygen deficiency increases the tumor’s
resistance toward cancer treatment modalities, including radiation and chemotherapy (25, 52, 53, 55, 104, 115, 126). In
addition, hypoxic microenvironments in tumors are known to
promote processes driving malignant progression, such as
angiogenesis, elimination of p53 tumor suppressor activity,
genetic instability, and metastasis (42, 52, 94). An understanding of tumor hypoxia could lead to the discovery of
diagnostic and prognostic markers for malignant progression,
discovery of novel therapeutic targets, and the development
of new constructs for gene therapy applications in human
cancer. Therefore, oximetry by PEDRI, which is a noninvasive and real-time measurement, is of importance in preclinical research. Since PEDRI also provides a quantitative
measurement, it is possible to track the change in oxygenation kinetics over days.
Figure 8 shows the enhancement of proton signal by the
Overhauser effect in an SCC VII tumor-bearing mouse (right
hind leg) by using two different EPR saturating power levels
(75). Electron spin-density images and oxygen images can
be obtained from these images. These oxygen images were
verified by a direct comparison with Eppendorf electrode
measurement. The pO2 images of the tumor (Fig. 8B) show
distinct intra-tumor heterogeneity with a gradation of oxygen concentration. The pO2 values range from hypoxic to

normoxic values (*50 mmHg) and are comparable with tumor pO2 values reported in using different invasive methods.
The imaging times ranged between 4 and 8 min, and degradation of pO2 maps caused by animal motion, system instability, and the contrast agent distribution were not observed
during this period. This study also shows that PEDRI is capable of monitoring changes in tumor oxygenation in response to the alteration of the breathing gas. In general, mean
pO2 values increased during carbogen (95% oxygen and 5%
carbon dioxide) breathing (Fig. 8C). In particular, the percentage of extremely hypoxic regions (*5 mmHg pO2) decreased *30% during carbogen breathing. The result
explains the previous reports that the treatment efficiency
improved when the tumor was oxygenated either by letting
the subject breathe carbogen (41, 50, 75, 91) or when the
patient was confined to a hyperbaric oxygen chamber (2, 6,
14, 22). The results from this study showed the capability of
PEDRI in obtaining quantitative maps of in vivo tumor oxygen status noninvasively.
Permeability Mapping with PEDRI

PEDRI can also be used for simultaneous assessment of
tumor pO2 as well as for permeability of the tumor vasculature since the TAM derivative Ox63 is localized to the extracellular, extravascular space in a similar way to the widely
used Gd3+ complexes. In normal tissue, there is a balance
between proangiogenic and antiangiogenic factors, where
mature vasculature with regular architecture ensures adequate supply of nutrients and oxygen. However, in tumors,
because of excess proangiogenic factors (37, 95), tumor neovasculature is abnormal and chaotic in architecture and has
poor structural integrity (61). The lack of adequate pericyte
and endothelial coverage results in large vascular pores,
causing a marked regional heterogeneity in tumor perfusion
and making the tumor vascular hyper-permeable (29, 62). As
a result, tumor progression is associated with disorganized
angiogenesis, which results in inadequate oxygen supply and
limited delivery of chemotherapeutics to the tumor (15, 63).
Thus, noninvasive vascular permeability imaging will be
useful in evaluating the tumor vasculature and choosing a
treatment strategy. Leakage of exogenously administered
tracers from blood vessels can be used to assess the tumor

PROTON-ELECTRON DOUBLE-RESONANCE IMAGING
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FIG. 8. PEDRI images (A) and
oxygen images (B, C) of anesthetized C3H mouse with an implanted SCC tumor. (A) PEDRI
with two different EPR irradiation
power (right: 3 W, left: 45 W). (B)
calculated pO2 map based on (A).
(C), pO2 images of a C3H mouse
with a 1-cm diameter SCC tumor
during air breathing (C, top) and
carbogen breathing (C, bottom).
The expanded tumor region, given
at right, clearly shows heterogeneity in pO2 distribution. Reprinted
with permission from Krishna et al.
(75). pO2, partial pressure of oxygen. To see this illustration in color, the reader is referred to the web
version of this article at www
.liebertpub.com/ars

vascular permeability (93). Especially the most commonly
used TAM (Ox63: molecular mass 1427) has a molecular
mass three times larger than typical gadolinium complexes,
which makes its endothelial transport more sensitive to microvascular permeability. With PEDRI, the tissue microvascular permeability imaging can be acquired by using the
same datasets that are needed for oximetry. The endothelial
transfer coefficient Ktrans was obtained from pharmacokinetics analysis of the contrast agent-induced dynamic signal
change that provides useful data to quantify the treatment
response in anticancer therapy.
Figure 9 shows the comparison of Ktrans maps of
gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)
and Ox63 with corresponding anatomy images (Fig. 9A)
(93). Relatively high Ktrans values were observed globally for
Gd-DTPA (Fig. 9B) compared with those for Ox63 (Fig. 9C)
in both tumor and normal tissue regions. The result was
consistent with its lower molecular mass, making it penetrate
easily even through the smaller pores in normal blood vessels
(21, 116). Therefore, the Ktrans of Gd-DTPA may have larger
contributions from blood perfusion in tissue than vascular
permeability as reported (4, 116). Figure 9D is a corresponding pO2 map computed from the same PEDRI images

for the Ox63 Ktrans map. The inverse relationship between
Ox63 Ktrans and pO2 suggested that the leaky and abnormal
tumor vasculature is unable to deliver oxygen efficiently to
tissue, in agreement with earlier studies using immunohistochemical analyses or oxygen-sensitive electrodes (28, 66).
This study showed that tumor regions with high vascular
permeability (Ktrans of Ox63) could be hypoxic regardless of
blood perfusion as determined by MRI using Gd-DTPA
(Ktrans of Gd-DTPA), suggesting that diffusion-limited hypoxia does not completely determine the oxygen status of tumors (Fig. 9D, F).
Redox Mapping with PEDRI

Oxidative stress is associated with various diseases such as
cancer, cardiovascular disease, Alzheimer’s disease (87),
Parkinson’s disease (64), diabetes mellitus (86), atherosclerosis (113), ischemia reperfusion injury (18), and chronic
inflammatory processes (24). The main causative factors are
reactive oxygen species, which also act as essential cellular
messengers and redox regulators (30). Therefore, developing
in vivo noninvasive redox imaging can shed light not only on
these pathologies but also on healthy tissue. Utsumi et al.
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FIG. 10. Reactions that cause loss of nitroxyl radicals.
Reprinted with permission from Utsumi and Hyodo (123).

FIG. 9. Comparison of Ktrans maps of Gd-DTPA and
Ox63 in an SCC tumor. (A) SCC tumor region can be
distinguished in a T2-weighted anatomic image by using 7-T
MRI. FOV = 32 mm. (B) Ktrans map of Gd-DTPA using 7-T
MRI in an SCC tumor-bearing mouse. (C) Ktrans map of
Ox63 using PEDRI of the same SCC tumor. Note that
PEDRI/Ox63 images were obtained before the 7-T MRI/GdDTPA study. (D) Corresponding pO2 map computed from
the same PEDRI images for Ktrans Ox63 map. (E, F) Based
on the anatomical image, ROI of SCC tumor was selected
and enlarged. Tumor region with low Ktrans Ox63 values
(ROI 1) was relatively oxygenated and normal muscle tissue, and the region with high Ktrans Ox63 values (ROI 2)
coincided with hypoxia in pO2 image. Reprinted with permission from Matsumoto et al. (93). Gd-DTPA, gadoliniumdiethylenetriamine pentaacetic acid; ROI, region of interest.
To see this illustration in color, the reader is referred to the
web version of this article at www.liebertpub.com/ars
utilized the PEDRI technique for redox imaging by using
redox-sensitive nitroxyl radical probes in vitro and in vivo by
using novel isotope-labeled probes (5, 57, 72, 90, 112, 125,
133). Nitroxyl radicals are known to lose their paramagnetic
property via a redox reaction with the hydroxyl radical or the
superoxide anion radical (Fig. 10) (76, 129). There is a good
linear relationship between the generation of hydroxyl radical and the loss of paramagnetism of nitroxyl radical (110).
It was also reported that cytochrome P-450, NAD(P)Hdependent cytochrome P450 oxidoreductase in microsomes
is associated with the loss of paramagnetism of nitroxyl
radical and the reduction of nitroxyl in the mitochondorial
electron transport system (58, 59, 103, 124). Glutathione and
ascorbic acid are also known to support the reduction of nitroxyl radical (23, 121), and the 2,2,6,6-ethyl substitution of

2,2,6,6-Tetramethyl-1-piperidinyloxy (TEMPO) led to resistance toward the reduction with ascorbic acid (71). In such
a manner, the nitroxyl radical directly and indirectly reflects
the redox state. Hence, analyzing the in vivo conversion rate
of the nitroxyl to the diamagnetic state enables visualization
of the redox state. Unlike the chemically stable TAM for
oximetry, nitroxyl radicals used for redox imaging need to
participate in redox reactions.
To optimize the adaptability of nitroxyl radicals as probes,
adequate modifications need to be made. Such chemically
modified nitroxyl radicals are preferentially distributed in
intracellular, extracellular, and cell membrane (109). A set of
redox-responsive probes to simultaneously assess redox reactions in intra- and extracellular regions were reported by
Utsumi et al. (125). With the design of 14N- and 15N-labeled
nitroxyls, it was possible to distinguish between intra- and
extracellular redox processes as demonstrated in a phantom
object.
The feasibility of redox imaging using nitroxyl radicals
was validated by in vitro experiments (Fig. 11), showing the
time-dependent redox reaction of both membrane-permeable
14 15
N/ N-3-methoxycarbonyl-2,2,5,5-tetramethyl-pyrrolidine1-yloxy (MC-PROXYL) and membrane-impermeable 14N/15N
carboxy-PROXYL. Images were acquired separately by
changing the external magnetic field for EPR irradiation
between 14N and 15N nuclei in FC-PEDRI (125). Figure 11A
is a schematic of seven phantom tubes comprising six outer
tubes with liposomes encapsulated with 100 mM ascorbic
acid: Two containing the 15N compounds are shown with red,
two containing the 14N compounds are shown with blue, and
two containing both compounds are shown by the red and
blue stripes. There was also one central tube, containing both
compounds and no liposomes. Carboxy-PROXYL does not
penetrate the liposome membrane, whereas MC-PROXYL
can permeate freely across the membrane and undergo 1electron reduction to the corresponding hydroxylamine.
Three such PEDRI images taken at 2.9, 13.9, and 24.9 min
are shown in Figure 11B. The image data showed that the
intensity from the tubes containing MC-PROXYL in the
presence of ascorbic acid-encapsulating liposomes gradually
decreased with time, whereas the image intensities from
tubes containing carboxy-PROXYL were constant. The rate
of intensity loss from each pixel represents the differential
redox imaging (Fig. 11C). It should be noted that the rate of
intensity loss in the tube containing both MC- and carboxyPROXYL (indicated with stripes in Fig. 11A) was the same
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FIG. 11. Simultaneous and time-dependent PEDRI of 15N/14N-carboxy- PROXYL and 15N/14N-MC-PROXYL in
liposomes encapsulating ascorbic acid (100 mM). (A) Seven phantom tubes containing 14N-labeled and/or 15N-labeled
nitroxyl radicals in the presence and the absence of liposomes were placed in the PEDRI so that images of 15N- and 14Nenhanced images (red and blue, respectively) in (B) were obtained simultaneously at the times shown in the figures. (B) The
presence of 15N-carboxy-PROXYL and 15N-MC-PROXYL are clearly shown by the red color, and 14N-carboxy-PROXYL
and 14N-MC-PROXYL are indicated by the blue color. (C) The images of the decay rates for 14N- and 15N-enhanced PEDRI images
were calculated by assuming first-order kinetics for the time-dependent decrease of the contrast (B). Only MC-PROXYL showed
decay images in both14N- and 15N-enhanced PEDRI (FOV, 48 · 48 mm; matrix, 64 · 64; slice thickness, 10 mm; TR/TE/TESR, 1200/
25/600 ms). Reprinted with permission from Utsumi et al. (125). MC-PROXYL, 3-MethoxyCarbonyl-2,2,5,5-Tetramethylpyrrolidine-1-yloxy. To see this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars

as that in the tube containing either MC- or carboxyPROXYL. Results from these phantom studies suggested that
if two nitroxyl radicals with different isotopic substitution
and different ring substituents (which direct them to different
subcellular regions) lose or gain their paramagnetism, then
their oxidation and reduction can be spatially resolved and
distinguished. The time-dependent signal loss of the PEDRI
images was observed when the nitroxyl radicals, which can
permeate the liposomal bilayer, underwent reduction;
whereas the nitroxyl agent incapable of crossing the membrane bilayer remained intact, and signal loss of the PEDRI
images was not observed. This capability demonstrated that
PEDRI combined with dual-labeled nitroxyl spin probes
enabled visualization of events occurring at a nanometer
scale, regardless of the intrinsic image resolution of 0.1 mm.
This capability further exploited the fact that nitroxyl radicals
are efficient antioxidants that also provide protection against
oxidative stress in several modalities.
Based on the results from in vitro experiments, in vivo
redox imaging using PEDRI was also successfully achieved.
Figure 12 shows in vivo redox imaging demonstrated in a
bupivacaine (BPVC)-induced local inflammation model in
mouse legs (36). BPVC is a clinically used local anesthetic
agent. However, it is known to destroy skeletal muscle fibers
and cause severe inflammation when injected (7, 77, 106).
Within several hours of BPVC-induced muscle transient fiber

destruction, inflammatory cells locally infiltrate into treated
tissues; the muscle cell itself regenerates within several
weeks. Because of this effect, BPVC treatment has been used
to create an animal model of muscle inflammation and regeneration. To noninvasively monitor redox status of the
muscle, in vivo PEDRI was performed at 4 and 24 h after
BPVC treatment in living mice. Two nitroxyl radicals, the
cell membrane penetrable (carbamoyl- PROXYL: Fig. 12A)
and the cell impermeable (carboxy-PROXYL: Fig. 12B),
were used in the in vivo PEDRI experiments to confirm
whether the redox reaction mainly occurs in the intracellular
or extracellular compartment. Nitroxyl radical solution was
carefully injected to the same region of the mouse leg that
had received BPVC pretreatment. After an injection of
carbamoyl-PROXYL, image intensities of both control and
BPVC-treated legs (at 4 or 24 h) were clearly enhanced, and
this intensity decreased over time. Although the image intensities of both legs were similarly decreased at 4 h after
BPVC treatment, the image intensity of the BPVC-treated leg
at 24 h showed faster decay than that of the untreated leg. The
redox maps clearly illustrated differences in decay rates and
distributions between control and BPVC-treated legs. The
average decay rate observed in the BPVC-treated legs of
eight mice significantly increased at 24 h but not at 4 h.
Differences in decay rates of BPVC-treated and contralateral
(nontreated) legs in individual mice were also calculated
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FIG. 12. Redox imaging of muscle in BPVC-treated mice by using in vivo DNP-MRI. (A) In vivo DNP-MRI images
and redox maps at 4 and 24 h after BPVC treatment in mice. Images were taken after injection of 2.5 mM carbamoylPROXYL (50 lL) into both legs. Redox maps were calculated by using four pharmacokinetic in vivo DNP-MRI images.
Decay rates were calculated for the DNP-MRI images of untreated and BPVC-treated legs. Plots showing differences
between decay rates in BPVC-treated versus untreated (contralateral) legs in individual mice. (B) In vivo DNP-MRI images
and redox map at 4 and 24 h after BPVC treatment in mice. Images were taken after injection of 2.5 mM carboxy-PROXYL
(50 lL) into both legs (N = 8 per group). *p < 0.01 (Other parameters are plotted as for carbamoyl-PROXYL.). Reprinted with
permission from Eto et al. (36). BPVC, bupivacaine; DNP, dynamic nuclear polarization. To see this illustration in color,
the reader is referred to the web version of this article at www.liebertpub.com/ars
(Fig. 12A, B, right panels). In these panels, a symbol above
the line marked ‘‘even’’ indicates that the decay rate of the
BPVC-treated leg was faster than that of the control leg.
It has been reported that probes that have multiple hyperfine lines can have efficient Overhauser enhancement. When

the MRI signal enhancement by saturating electron of such
probes is enough to visualize in vivo free radicals, several
endogenous antioxidants can be used as redox-responsive
PEDRI probes. In contrast to administering the redoxsensitive nitroxyl probe and observing the loss of signal, the
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attempt to visualize and identify various endogenous free
radical intermediates derived from redox transformations
was tested (56, 123).
Figure 13 shows the EPR signals of the intermediate of
various candidate probes (56). The enhancements due to
FADH and FMNH were similar to that induced by carbamoylPROXYL (enhancement factor = 3.8, 4.3, and 3.3, respectively), even though the EPR absorption spectra of both
FMNH and FADH exhibit a 13-fold broader line width,
compared with the spectrum of carbamoyl-PROXYL, and the
ratios of enhancement factor to peak height of both FMNH and
FADH were four to seven times higher than that of carbamoylPROXYL. The line widths varied from 4.2 MHz (carbamoylPROXYL) to 58.5 MHz (FMN), which were much larger than
the MRI resonance frequency. EPR excitation for PEDRI was
carried out under continuous-wave irradiation, and the fluctuation of EPR irradiation was estimated within 1 ppm (corresponding to 0.5 kHz), which probes only a small proportion
of the free radical molecules. This allows the electron transitions to be saturated much less completely in FMNH and
FADH solutions than in carbamoyl-PROXYL solution. The
coenzyme Q10 (CoQ10)H and radicals of vitamins E and K all
enhanced the proton signals of the nonaqueous solvent: acetone
for CoQ10H, hexane for the vitamin E radical, and CHCl3/
EtOH for the vitamin K radical. Compared with carbamoyl-

FIG. 13. Typical EPR
spectra (A), the absorption
EPR spectra (B), and simultaneous DNP-MRI image (C) of free radical
intermediates from FMN,
FAD, CoQ10, vitamin E,
vitamin K1, and the synthetic stable radical 14 Ncarbamoyl-PROXYL. The
vertical solid line in part b
indicates the frequency of
EPR irradiation for PEDRI
(527.5 MHz), which is the
resonance frequency of the
central peak of carbamoylPROXYL. MRI spectra with
and without EPR irradiation
were obtained with a spin
echo sequence at 850 kHz by
using a homemade in vivo
PEDRI system kept at room
temperature. Reprinted and
adapted with permission from
Hyodo et al. (56). ª 2014
American Chemical Society.
FMN, flavin mononucleotide;
FAD, flavin adenine dinucleotide. To see this illustration in color, the reader is
referred to the web version of
this article at www.liebertpub
.com/ars
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PROXYL, the ratio of enhancement factor to peak height was
38 times higher for the vitamin K1 radical, 5 times higher for
the vitamin E radical, and 2 times higher for CoQ10H. Also, the
electrons of these probes can be separately saturated and induce
DNP by adjusting the EPR irradiation frequency. The result
indicates that it is possible to simultaneously visualize various
free radical intermediates of endogenous redox molecules (56).
pH Mapping with PEDRI

Aberration of normal tissue pH homeostasis in the human
body has been reported for a number of pathological conditions that include cancers (123, 135), myocardial (98) and
brain ischemia (73, 132), and chronic pulmonary (60) and
kidney diseases (74). The extracellular tumor tissue acidosis,
pHe, has been identified as a significant factor in cancer
pathophysiology contributing to tumor initiation, progression, and therapy (43). Therefore, in vivo pHe imaging of the
tumor tissue microenvironment (TME) may provide an invaluable tool for diagnosis, understanding of disease progression, and treatment optimization. Recently developed
variable field (VF) (69) and variable radio frequency (VRF)
PEDRI (33) approaches allow for functional mapping using
nitroxide or trityl probes while additionally keeping the capability to provide anatomical images. VF (69) and VRF
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FIG. 14. FC-DNP spectra of the nitroxide NR1 obtained in phosphate–citrate buffer (10 mM each) at pH
7.62 (A) and pH 4.98 (B), and the scheme of the reversible protonation of the NR1 radical, pKa 5 6.1 (C).
Frequency of EPR irradiation 563.2 MHz, irradiation time,
500 ms, repetition time, 1140 ms; step size = 0.04 G; P = 0.8 W,
sample volume, 5 mL. The preferable resonance structures of
protonated, RH+, and unprotonated, R, forms are shown illustrating higher unpaired electron density on nitrogen atom
N-1 in the unprotonated form. Protonation results in a DNPdetected difference in hyperfine splitting (DaN = 0.8 G) between R and RH+ forms. A dotted line is extended from
low- and high-field peaks of the spectra (B) to aid the eye.
Reprinted with permission from Khramtsov et al. (69).
PEDRI (33) approaches allow for mapping the chemical
microenvironment by using probes with functionally dependent ratiometric spectral parameters. The valuable spectral parameters at each pixel can be extracted from a limited
number of PEDRI acquisitions acquired at preselected EPR
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excitation fields or EPR excitation frequencies. This allows
for functional mapping using specifically designed paramagnetic probes, together with high-quality spatial resolution and short acquisition time. The concept was first
verified by using VF PEDRI and a pH-sensitive nitroxide
probe (69).
Figure 14 shows typical DNP spectra of the nitroxide NR1
acquired in acid, pH 4.98, and slightly alkaline, pH 7.62,
aqueous solutions corresponding to dominant contributions
of the protonated, RH+, and nonprotonated, R, forms of the
radical, correspondingly, pKa = 6.1 (70). The significantly
larger distance between the outer lines of the triplet spectra
observed for the alkaline solution of the nitroxide is in
agreement with previously reported larger nitrogen hyperfine
splitting (hfs) for the R form (70).
The chemical equilibrium shown in Figure 14 illustrates
the effect of protonation of the atom N-3 of the radical heterocycle resulting in decreasing unpaired electron density at
the nitrogen nucleus of the N-O fragment, and, as a consequence, in lowered hfs for the RH+ form. Note that at low
EPR frequency, 563.2 MHz in Figure 14, the three lines of the
spectrum are unequally spaced due to the Breit–Rabi effect
(13, 102).
The pH-dependent DNP spectral changes allow for preferable excitation of EPR resonances of R or RH+ forms of the
nitroxide NR1 as illustrated in Figure 15 for the phantom
sample of the two tubes filled with an aqueous solution of
NR1 titrated to alkaline and acidic pH values. The stepped
variation of the EPR irradiation field, BEPR, resulted in the
subsequent changes in image intensity with the maximal
image intensities of alkaline (predominantly R form) and
acidic (predominantly RH+ form) solutions when BEPR is
equal to 83.2 G and 84 G, respectively. Note that the observed
0.8 G difference in BEPR values between the brightest images
of R and RH+ forms is in excellent agreement with the
maximal pH-dependent change of hfs shown in Figure 14.

FIG. 15. Sequence of PEDRI images of the phantom sample of a
pair of tubes, 10 mm diameter, containing 1 mM aqueous solutions of
the NR1 probe at pH 9 (left tube)
and pH 2 (right tube). Images were
acquired at EPR frequency 282 MHz
(100 G for the EPR center field) with
evolution field stepped in the range
from 83.0 G to 84.4 G around the position of the low-field EPR component
of the NR1 triplet spectrum. The observed variation of the image intensity
with the shift in EPR irradiation field,
BEPR, illustrates the subsequent changes with the maximal image intensity
of R form (left tube) and RH+ form
(right tube) when BEPR is equal to
83.2 G and 84 G, respectively. Reprinted with permission from Khramtsov et al. (69).
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FIG. 16. (a, b) The chemical structures and proton
exchange equilibrium for pH-sensitive nitroxide, NR2,
and trityl, HOPE, probes. HOPE, trityl probe with spectral sensitivity to pH, pO2, and Pi in extracellular tissue
microenvironment.
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Based on the data shown in Figure 15, EPR excitation at
the field values that coincide with DNP spectral peak positions of RH+ and R forms of the probe will generate two
PEDRI images with signal intensities that are proportional to
the concentrations of the corresponding ionization states of
the probe. Taking into account that the ratio of concentrations
of protonated and nonprotonated forms of the probe is directly related to pH ([RH+]/R) = ([H+]/Ka), this provides an
opportunity to convert these two PEDRI images into a pH
map.
Alternatively to VF PEDRI, the VRF PEDRI approach
uses a stationary magnetic field but different EPR radio frequencies (RF). The ratio of Overhauser enhancements measured at each pixel at two different excitation frequencies
corresponding to the resonances of protonated and deprotonated forms of a pH-sensitive nitroxide is converted to a pH
map by using a corresponding calibration curve. Elimination
of FC decreased the acquisition time by exclusion of the
periods of ramping and stabilization of the magnetic field.
Improved magnetic field homogeneity and stability allowed
for the fast MRI acquisition modalities such as fast spin echo.
In total, about a 30-fold decrease in EPR irradiation time was
achieved for VRF PEDRI (2.4 s) (69) compared with VF
PEDRI (70 s) (33), as tested with similar aqueous solutions of
the NR1 radical. This is particularly important for in vivo
applications enabling one to overcome the limiting stability

FIG. 17. VRF PEDRI pH calibration (A–D) and in vivo pH mapping (E, F) by using NR2 probe. Calibration has been
performed by using a 10-tube phantom (A) at room temperature. PEDRI images were acquired at two EPR irradiations,
RF2 = 559.3 MHz (B) and RF1 = 562.1 MHz (C), acquisition time, 8.4 s. The tube with water alone is not visible on either
image due to lower intensity compared with the signal from tubes containing the paramagnetic probe. EPR off image (not
shown) was subtracted from both EPR on images acquired at RF1 and RF2, yielding image intensities, I(RF1) and I(RF2).
(D) pH dependence of the ratio I(RF1)/(I(RF1)+I(RF2)). Solid line is nonlinear least-squares fit of the data to a conventional
titration equation, yielding pKa value equal to 6.75 – 0.05. Error bars represent the standard deviation. In vivo PEDRI pH
mapping was performed in the anesthetized breast tumor-bearing mouse (E, F). Paramagnetic NR2 probe was injected into
the tumor (number 4 mammary gland, left) and normal mammary gland (number 9, right). (E) Qualitative visualization of
the distribution of the NR2 probe, in vivo. The image is the average of two PEDRI images acquired at two EPR frequencies,
RF1 = 562.1 MHz and RF2 = 559.3 MHz, NMR frequency, 784.9 kHz, matrix, 64 · 64; field of view, 80 · 80 mm. Irradiation
time was 8.4 s for each acquisition. (F) pH map (in color) calculated from two PEDRI images superimposed with the MRI
image (gray scale) showing the coronal view of the mouse. Reprinted and adapted with permission from Samouilov et al.
(108). ª 2014 American Chemical Society. VRF, variable radio frequency. To see this illustration in color, the reader is
referred to the web version of this article at www.liebertpub.com/ars
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of paramagnetic probes and sample overheating by reducing
RF power deposition.
To perform PEDRI pHe mapping of TME, there is a need
for paramagnetic pH probes that meet the following requirements: (i) appropriate pKa values in the range from 6.1
to 6.9 that allow pH measurements of slightly acidic TME pH
values; (ii) comparatively narrow linewidth to obtain a high
enhancement and decreased RF power deposition; (iii) sufficient stability of paramagnetic fragments in a highly reducing tumor microenvironment; and (iv) a hydrophilic
structure that ensures extracellular probe localization. The
nitroxide NR1 used to prove the concept of VF and VRF
PEDRI (33, 69) has a very short life-time in vivo due to its fast
reduction to the corresponding hydroxylamine and its applications in vivo are hardly possible.
The nitroxide NR2 represents the structure (Fig. 16a) of a
paramagnetic pH probe carefully designed for in vivo monitoring of pHe in TME. The pKa value of the probe has been
tuned by a variation of substitute at position 4 of the radical
heterocycle, resulting in an optimal range of pH sensitivity
centered at slightly acidic pHe of TME (pKa = 6.6 at 37C).
Partial deuteration of the NR2 resulted in the narrowing EPR line
(1.2 G for NR2 vs. 2.1 G for undeuterated analog) required for
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efficient saturation by RF irradiation, which is of critical importance for obtaining higher PEDRI enhancement and allowing
for a shorter acquisition time. The bulky ethyl substitutes at
positions 2 and 5 of the radical heterocycle of the NR2 serve to
protect the paramagnetic NO fragment against bioreduction,
significantly enhancing its biostability. Extracellular localization
of the probe has been achieved by binding the nitroxide label to
hydrophilic tripeptide, glutathione, preventing the resulting NR2
probe from diffusion across the hydrophobic lipid bilayer of the
biomembranes and, therefore, enforcing probe localization in
extracellular aqueous volumes (108).
Figure 17A–D shows the pH calibration of the NR2 probe
using VRF PEDRI obtained for a 10-tube phantom (Fig. 17a)
containing the NR2 solutions of different pH values. EPR
frequencies were preselected to correspond to the maximal
NMR intensities of R and RH+ forms. A fast spin echo sequence has been applied with an acquisition time of 8.4 s
for each image (Fig. 17B, C). The EPR off image was subtracted from both EPR on images acquired at RF1 and
RF2, yielding image intensities, I(RF1) and I(RF2), respectively. The pH dependence of intensities ratio I(RF1)/
(I(RF1)+I(RF2)) shown in Figure 17D is described by the
titration curve with the observed pKa value of NR2 probe

FIG. 18. VRF PEDRI pH calibration (A–D) and dual function pH and pO2 mapping (E, F) by using trityl HOPE
probe. The phantom used for pH calibration consists of 9 sealed glass tubes filled with 1 mL of degassed 0.5 mM probe
solutions, 150 mM sodium chloride, at different pH values indicated in the (A), and one reference tube filled with degassed
solution of sodium chloride only. Images were acquired by using RF1 = 573.625 MHz (B) and RF2 = 573.95 MHz (C) EPR
irradiation frequencies, respectively; NMR frequency, 856 kHz, irradiation time, 130 s; matrix, 64 · 64; field of view,
80 · 80 mm. (D) pH dependence of the ratio I(RF1)/(I(RF1)+I(RF2)). Solid line is nonlinear least-squares fit of the data to a
conventional titration equation, yielding pKa value equal to 6.9 – 0.03. (E, F) PEDRI mapping of pH and pO2 of a phantom
sample. The sample consisted of four tubes filled with 1 mM solution of HOPE probe of different oxygen concentrations and
pH values (indicated in Fig. 18E, F, respectively). PEDRI images were acquired at two frequencies of EPR radiation,
456.6 MHz and 457 MHz, and at two power values, 0.5 W and 4.0 W. The calculated pH values are 6.72 – 0.05, 7.04 – 0.05,
7.27 – 0.05, and 7.45 – 0.07, and pO2 values are 5 – 3, 14 – 3, 35 – 4, and 81 – 6 mmHg. MRI data were acquired by fast spin
echo method, matrix size, 64 · 64; field of view, 40 · 40 mm, NMR frequency, 686.3 kHz; total acquisition time, 4.2 min.
(A–D) Reprinted with permission from Takashi et al. (122). (E, F) are provided through the courtesy of Artem Gorodetskii,
IMMR center, WVU. To see this illustration in color, the reader is referred to the web version of this article at www.
liebertpub.com/ars
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equal to 6.75 – 0.05 in agreement with the EPR-measured
pKa value, 6.74 – 0.05 (108).
Figure 17E, F demonstrates the application of VRF PEDRI
for pHe mapping of living tissue in the tumor-bearing mouse
by using the NR2 radical. Two PEDRI images are acquired
during 8.4 s EPR irradiation at two preselected EPR frequencies, which correspond to EPR resonances of RH+ and R
forms of deuterated NR2 probe. The ratio of the signal intensities of these two images corresponds to the [RH+]/[R]
ratio, therefore allowing the conversion of two PEDRI images into a pH map by using the calibration curve shown in
Figure 17D. The probe distribution area in tumor (Fig. 17E
left) is about 1 cm2, which is close to the value of the tumor
cross-sectional area (the measured tumor size is about
1.2 · 0.9 cm), therefore supporting probe localization within
the tumor. The probe distribution area in the mammary gland
(Fig. 17E right) is less than 0.2 cm2, being close to its size.
Figure 17F shows a pH map (in color) superimposed with
low-field MRI (gray scale) representing the coronal view of
the mouse. The broader pHe distribution in tumor in the range
from 6.4 to 7.1 compared with pHe distribution in the
mammary gland from pH 7.0 to 7.2 was observed in agreement with high heterogeneity of the tumor microenvironment. Average values of pHe in tumor and mammary gland
were found to be 6.8 – 0.1 and 7.1 – 0.1, respectively, supporting significant tumor tissue acidosis. Note that a sufficiently slow reduction of the NR2 even in highly reducing
tumor tissue (half-life of about 5 min) allowed for quantitative assessment of spatially resolved information on tissuereducing capacity in complement to pH measurements (12) by
mapping decay of the PEDRI signal at each pixel. Therefore,
the same pH probe can be used for simultaneous mapping of
pH and redox status.
Trityl radicals have advantages over nitroxides for in vivo
PEDRI applications due to their extraordinary high stability
in living tissues and long relaxation times, allowing for a
maximum saturation with limited RF power deposition.
These compounds were first developed for biomedical applications by Nycomed Innovation (119) and have been used
for in vivo EPR (34) and PEDRI oximetry (75). In addition,
trityl derivatives containing amino (27) or phosphono groups
(26) demonstrate dual function oxygen and pH spectral
sensitivity. Recently, trityl probe with spectral sensitivity to
pH, pO2, and Pi (inorganic phosphate) in an extracellular
tissue microenvironment (termed HOPE probe, see Fig. 16b)
has been synthesized (10, 26) and used for concurrent multifunctional assessment of TME in tumor-bearing mice by
using low-field EPR spectroscopy (11). In our opinion, the
PEDRI approach in combination with the HOPE probe provides an opportunity for multifunctional mapping of a tissue
microenvironment in living subjects.
Figure 18A–D shows VRF PEDRI pH calibration performed by using a phantom sample containing anoxic solutions of the HOPE probe at different pH values. Acquisitions
of two PEDRI images obtained with EPR irradiations at two
preselected EPR frequencies that correspond to maximal
NMR intensities of R and RH+ forms of the HOPE probe
(Fig. 16) allow one to calculate the pH calibration curve
shown in Figure 18D (cf. with Fig. 17A–D for the NR2)
(122). In case of dual pH and oxygen mapping, the number of
acquisitions has to be extended by the addition of PEDRI
images acquired at different RF powers to assess oxygen
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concentration (75). Figure 18E, F illustrates dual-function pH
and pO2 mapping of a phantom consisting of four tubes
prepared with different pH and oxygen concentrations and
obtained by acquisition of a total of four PEDRI images at
different EPR frequencies (x2) and different RF powers (x2).
The conversion of these images to pH (Fig. 18E) and oxygen
(Fig. 18F) maps with spatial resolution of 0.6 mm and field of
view 40 · 40 mm2 provides functional accuracy of about 0.05
pH units of pH and 3–4 mmHg of pO2 for the physiologically
relevant pH and oxygen ranges. The calculated mean values
of pH and pO2 are in reasonable agreement with the experimental ones. Note that acquisition of additional PEDRI images at intermediate EPR frequency, (RF1+RF2)/2, may
provide information on the spatial distribution of phosphate
due to the fact that Pi facilitates proton exchange between R
and RH+ forms of the HOPE probe, therefore resulting in
appearance of EPR signal intensity at the intermediate EPR
frequency (see review (68) for details).
In summary, VF and VRF PEDRI techniques in
combination with functional paramagnetic probes offer an
opportunity for the mapping of specific parameters of a
local chemical microenvironment, including measurements
in vivo. Application of multifunctional radicals such as
HOPE probes can further extend the capability of PEDRI
for concurrent mapping of several chemical parameters of a
local microenvironment.
Conclusions

PEDRI has been developed since the 1980s as a free radical imaging method based on the Overhauser effect. It has
proved to be applicable to in vivo imaging by introducing
optimal tracers and pulse sequences. The possibility of generating high-resolution PEDRI images with corresponding
anatomical images has realized the quantitative measurement
of pO2, tissue permeability, redox status, and pH. Such
functional information obtained from PEDRI has been applied to various disease models, preclinically giving insights
into the pathology and etiology of human disease.
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Abbreviations Used
BPVC ¼ bupivacaine
CoQ10 ¼ coenzyme Q10
DNP ¼ dynamic nuclear polarization
EPR ¼ electron paramagnetic resonance
EPRI ¼ electron paramagnetic resonance imaging
FAD ¼ flavin adenine dinucleotide
FC ¼ field cycling

FMN ¼ flavin mononucleotide
Gd-DTPA ¼ gadolinium-diethylenetriamine pentaacetic
acid
hfs ¼ hyperfine splitting
HOPE ¼ trityl probe with spectral sensitivity
to pH, pO2 , and Pi (inorganic phosphate)
in extracellular tissue microenvironment
MC-PROXYL ¼ 3-MethoxyCarbonyl-2,2,5,5-Tetramethylpyrrolidine-1-yloxy
MRI ¼ magnetic resonance imaging
NMR ¼ nuclear magnetic resonance
NOE ¼ nuclear Overhauser effect
OMRI ¼ Overhauser-enhanced magnetic resonance
imaging
PCA ¼ proxyl carboxylic acid
PEDRI ¼ proton-electron double-resonance imaging
pO2 ¼ partial pressure of oxygen
RF ¼ radio frequency
ROI ¼ region of interest
SAR ¼ specific absorption rate
SNR ¼ signal-to-noise ratio
TAM ¼ triarylmethyl or trityl radical
TEMPO ¼ 2,2,6,6-tetramethyl-1-piperidinyloxy
TEMPOL ¼ 4-hydroxy-2,2,6,6-tetramethylpiperidine1-oxyl
TME ¼ tumor tissue microenvironment
VF ¼ variable field
VRF ¼ variable radio frequency

